A Study of 13vPnC Safety in Healthy Adults 18 to 49 Years Old in India
A Phase 4, Open-Label, Single-Arm, Multicenter Study to Describe the Safety of 13- Valent Pneumococcal Conjugate Vaccine in Adults 18 to 49 Years of Age in India
Category & Conditions: Vaccine-related Conditions
Medicine: PREVNAR 13(PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE [DIPHTHERIA CRM197 PROTEIN])
ClinicalTrials.gov Identifier (NCT): NCT05329259
Protocol ID: B1851214
PrintDownloadOpen Plain Language Summary Result: Click here